PROGmiR statistics

info info

Citations per year


Popular tool citations

chevron_left Prognostic biomarker identification chevron_right

Tool usage distribution map

Tool usage distribution map
info info

Associated diseases

Associated diseases
Want to access the full stats & trends on this tool?

PROGmiR specifications


Unique identifier OMICS_12522
Name PROGmiR
Interface Web user interface
Restrictions to use Academic or non-commercial use
Programming languages PHP, R
Computer skills Basic
Version 2.0
Stability Stable
Maintained Yes


  • person_outline Chirayu Pankaj Goswami

Publication for PROGmiR

PROGmiR citations


The impact of Mir 9 regulation in normal and malignant hematopoiesis

PMCID: 5939831
PMID: 29774136
DOI: 10.4081/oncol.2018.348

[…] in leukemic patients., after determining the expression of mir-9 in different leukemias, we have tried to find the relationship of mirr-9 expression with survival of leukemia patients using progmir database. as shown in , a high expression level of mir-9 significantly reduced survival rate of aml patients [p=0.049, hazard ratio=1.07 (1-1.14)]. this finding might show the prognostic […]


Arsenic trioxide mediated suppression of miR 182 5p is associated with potent anti oxidant effects through up regulation of SESN2

PMCID: 5882315
PMID: 29662624
DOI: 10.18632/oncotarget.24678

[…] (figure )., because ato could suppress mir-182-5p and lead to up-regulation of sesn2, it is interesting to investigate whether these genes would be associated with overall survival of patients. progmir [] and precog [] were two online tools used for assessment of specific microrna and mrna on the survivals of different cancer types, respectively. the datasets were retrieved from geo […]


HDAC2 and HDAC5 Up Regulations Modulate Survivin and miR 125a 5p Expressions and Promote Hormone Therapy Resistance in Estrogen Receptor Positive Breast Cancer Cells

Front Pharmacol
PMCID: 5736991
PMID: 29326587
DOI: 10.3389/fphar.2017.00902

[…] breast cancer stratified by mir-125a-5p expression levels (low and high) were evaluated using kaplan–meier analysis from a publicly available prognostic mirna online database and web tool (progmir v2) (). the roc analysis was constructed to quantify the accuracy of target genes (hdac2 and birc5) using the sigmaplot spw10.0 software. the area under the curve (auc) is a combined measure […]


A comprehensive insight into the clinicopathologic significance of miR 144 3p in hepatocellular carcinoma

PMCID: 5513884
PMID: 28744145
DOI: 10.2147/OTT.S138143

[…] rather than low pathologic stage. no significant correlation was observed between mir-144-3p and other clinicopathologic features. in the survival analyses by prog-mir (, no significant results were observed (hazard ratio =0.93, 95% ci: 0.83 to 1.04, p=0.204)., in contrast to the adjacent normal liver tissue (2.6200±0.9263), mir-144-3p was significantly […]


Hinokitiol up regulates miR 494 3p to suppress BMI1 expression and inhibits self renewal of breast cancer stem/progenitor cells

PMCID: 5652685
PMID: 29100291
DOI: 10.18632/oncotarget.18648

[…] dataset (overall survival among er+ breast cancer patients) by mirumir (figure ) and the cancer genome atlas (tcga) dataset (metastasis-free survival among invasive breast carcinoma patients) by progmir v2 online tools (figure ). the results showed that the lower expression of mir-494 had a significant poor survival time (figure , p= 0.00113 for gse37405 and p=0.0125 for tcga dataset). […]


MicroRNAs in the prognosis of triple negative breast cancer

PMCID: 5459744
PMID: 28562579
DOI: 10.1097/MD.0000000000007085

[…] a sample size less than 30 cases; calculated hrs based on a combination of multiple mirs; lacked sufficient data for estimating hrs and 95% cis; or used survival data that originated from the tcga, progmir, metabric, or breastmark dataset. data were extracted from articles fulfilling all the aforementioned selection criteria. two individual investigators (ll and xm) independently assessed […]

Want to access the full list of citations?
PROGmiR institution(s)
Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, IN, USA; Departments of Surgery, Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, USA
PROGmiR funding source(s)
This study was partly supported by IUPUI Breast Cancer Signature Center and Susan G. Komen for the Cure grant SAC110025.

PROGmiR reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review PROGmiR